Tuesday's Early Winners & Losers

InterMune(ITMN Quote) soared 29% in postclose trading Monday after the Brisbane, Calif.-based biotech scored an exclusive worldwide collaboration agreement with Swiss-based Roche for hepatitis C drugs.

The companies plan to develop and commercialize products from InterMune's HCV protease-inhibitor program. The company said it will get a $60 million upfront payment and up to $470 million in milestones. The agreement includes InterMune's ITMN-191, a compound expected to enter clinical trials before the end of the year. The companies will also collaborate on a research program to identify, develop and commercialize second-generation HCV protease inhibitors. Shares skyrocketed $4.88 and were trading around $21.71.

Stanley Furniture(STLY Quote) sank after the Stanleytown, Va.-based furniture maker posted a drop in third-quarter earnings. The company reported income of $3 million, or 26 cents a share, compared with $5.8 million, or 44 cents a share, during the same period in the prior year. Revenue dropped 11.3% to $75.9 million. Analysts polled by Thomson First Call were looking for earnings of 28 cents a share on revenue of $77.5 million.

Looking ahead, Stanley Furniture said it expects fourth-quarter earnings in the range of 13 cents to 16 cents a share and sales in the range of $69 million to $71.5 million. Wall Street is looking for a profit of 25 cents a share on $75.8 million in sales. For the full year, earnings are expected to be in the range of $1.15 to $1.18 a share, and total-year sales are expected to be in the range of $305.9 million to $308.4 million. Shares were tumbling $2.54, or 11.7%, to $19.20.